Relapsing De Novo Membranous Nephropathy
Allograft membranous glomerulopathy can be a recurrent or de novo disease. Both instead have different underlying immune pathophysiology and disease pattern. While the introduction of ANTI-PLAR2 and THS7A brought new insights into the management of Immune/primary MN, the treatment of de novo MN is n...
Saved in:
Main Authors: | Ala Ali, Huda Al-Taee, Thaer J. Kadhim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Transplantation |
Online Access: | http://dx.doi.org/10.1155/2022/6754520 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Malignancy in Membranous Nephropathy: Evaluation of Incidence
by: Basil Alnasrallah, et al.
Published: (2017-01-01) -
Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
by: Claire Kennedy, et al.
Published: (2013-01-01) -
Update on New Antigens in the Pathogenesis of Membranous Nephropathy
by: Maurizio Salvadori, et al.
Published: (2022-09-01) -
A Case of Severe and Refractory Membranous Nephropathy Associated to Mucous Membrane Pemphigoid
by: Eric Mereniuk, et al.
Published: (2021-01-01) -
Crescentic Glomerulonephritis and Membranous Nephropathy: A Rare Overlap
by: Mohamedanwar Ghandour, et al.
Published: (2022-01-01)